Explained herein are pharmaceutical packaging units which reduce oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-delicate medications, such units like a syringe with the oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with very reduced permeability to oxygen and comprises ethyl